4-Methoxy-N-(2,4,6-triMethylphenyl)benzenesulfonaMide, 97%
|
|
|
- CAS-Nr.
- 349085-82-1
- Englisch Name:
- 4-Methoxy-N-(2,4,6-triMethylphenyl)benzenesulfonaMide, 97%
- Synonyma:
- CS-2460;SK 137647;GSK137647;GSK137647A;GSK137647A, >98%;GSK137647A ，S0001;GSK137647A, 10 mM in DMSO;FFA4 (GPR120) agonist GS137647A;FFA4 (GPR120) agonist GSK137647A;Benzenesulfonamide, 4-methoxy-N-(2,4,6-trimethylphenyl)-
- CBNumber:
- CB22635143
- Summenformel:
- C16H19NO3S
- Molgewicht:
- 305.39
- MOL-Datei:
- 349085-82-1.mol
|
4-Methoxy-N-(2,4,6-triMethylphenyl)benzenesulfonaMide, 97% Eigenschaften
- Siedepunkt:
- 438.1±55.0 °C(Predicted)
- Dichte
- 1.214±0.06 g/cm3(Predicted)
- storage temp.
- 2-8°C
- L?slichkeit
- Soluble to 100 mM in DMSO and to 50 mM in ethanol.
- Aggregatzustand
- powder
- pka
- 9.23±0.10(Predicted)
- Farbe
- white to beige
- Stabilit?t:
- Stable for 2 years from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20° for up to 1 month.
- CAS Datenbank
- 349085-82-1
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
4-Methoxy-N-(2,4,6-triMethylphenyl)benzenesulfonaMide, 97% Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
4-Methoxy-N-(2,4,6-trimethylphenyl)benzenesulfonamide is involved in long-chain fatty acid stimulated GLP-1 secretion and has been implicated in glucose homeostasis, adiposity, and regulation of the anti-inflammatory response. It enhances glucose-stimulated insulin secretion in MIN6 cells. It induces intracellular calcium accumulation in U2OS cells; this activity is inhibited by AH 7614.
4-Methoxy-N-(2,4,6-triMethylphenyl)benzenesulfonaMide, 97% Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
4-Methoxy-N-(2,4,6-triMethylphenyl)benzenesulfonaMide, 97% Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 135)Lieferanten
349085-82-1()Verwandte Suche:
- 4-Methoxy-N-(2,4,6-triMethylphenyl)benzenesulfonaMide, 97%
- GSK137647A
- GSK137647
- 4-Methoxy-N-(2,4,6-triMethylphenyl)benzenesulfonaMide,97%
- GSK137647A;GSK-137647A;GSK 137647A;GSK-137647;GSK 137647
- GSK137647A, >98%
- CS-2460
- FFA4 (GPR120) agonist GS137647A
- Benzenesulfonamide, 4-methoxy-N-(2,4,6-trimethylphenyl)-
- FFA4 (GPR120) agonist GSK137647A
- SK 137647
- GSK137647A, 10 mM in DMSO
- GSK137647A ，S0001
- 349085-82-1
- API
